Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-01-07 @ 11:06 AM
Study NCT ID:
NCT02094560
Status:
TERMINATED
Last Update Posted:
2018-09-05
First Post:
2014-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
Sponsor:
CellAct Pharma GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-18
First Submit QC Date:
None
Study First Post Date:
2014-03-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-31
Last Update Post Date:
2018-09-05
Last Update Post Date Type:
ACTUAL